tirzepatide liver disease for weight loss treats fatty in Phase 2 trial Tirzepatide-Induced Liver Injury: A Rare...

Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate

baseline characteristics are summarized in Table 2

10.1016/j.devcel.2018.10.017 125

GLP-1 agonists may improve metabolic aspects but remain off-label for this indication

PlexusDx recognizes that side effect management is integral to treatment adherence, which is why nutritional supportincluding magnesium optimizationcomplements personalized GLP-1 therapy

Bottom line: At this point, there is no clear evidence that GLP-1 agonists cause depression or suicidal behavior in the average patient, but there are signals that merit caution